Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

Scientists say the current COVID vaccine is effective against the Nimbus variant and is considered a “variant under ...

According to WHO, globally, this variant contributed to 23 per cent of global COVID-19 cases as of last month.

Amid growing concerns over the safety of COVID-19 vaccines, a significant lawsuit against prominent figures in the pharmaceutical industry and public health has taken a dramatic turn. Three new ...

The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...

A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...

A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.

DOJ filed the statement of interest in United States District Court for the case Children’s Health Defense et al. v. Washington Post et al., which lists among its defendants the BBC, Reuters, the ...

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...

Just five years after the coronavirus pandemic struck, another animal-borne disease is mutating and spreading across borders ...